Asthma Treatment Market: Increasing Penetration of Generic Drugs to Drive Sluggish Growth

The global asthma treatment market will rise from a value of ~US$ 25.6 Bn in 2019 to ~US$ 30.5 Bn by 2027, and it is anticipated that an increase in the number of FDA-approved products in parallel to the increasing awareness among asthma patients regarding quality care will drive the steady odyssey of the market.

Analysts at Transparency Market Research (TMR) anticipate that, among the strategic approaches taken towards consolidation, partnerships and collaborations will remain integral to maximize profitability from new markets. Having witnessed product recalls, manufacturers in the asthma treatment market are dedicating ample efforts to develop high-quality products, which are likely to receive easy approvals from the FDA and similar regulatory bodies.

On the demand side, as awareness regarding quality care for the treatment of asthma increases among patients, the adoption of inhalers and oral drugs is likely to increase. However, in recent times, the cost-benefits of generic drugs have been appealing to patients, which could pose as a challenge for manufacturers in the asthma treatment market.

asthma treatment market infographic

To know the scope of our report Get a Sample on Asthma Treatment Market 

Consumer Shift towards Alternative Therapies to Impede Revenue of Asthma Treatment Market

The consumption of antibiotics for the treatment of asthma has always been debatable, given their side-effects such as include sore mouth and throat, dysphonia, cough, and spasms of the trachea. In addition, several patients have also complained of suffering from headaches, increased heart rates, and tremors, post the intake of drugs, which has instigated the quest for asthma treatment that is free from any side-effects, such as alternative therapies.

Despite not being branded as the mainstream treatment, individuals in the modern era are showing a marked proclivity for alternative therapies as an additional measure to treat asthma. Another challenge for market players is the mounting amount of literature that claims the effectiveness of alternative therapies when practiced for a prolonged period of time. This has attracted the interest of practitioners as well as asthma patients towards alternate therapies, as such impeding the growth of the global asthma treatment market.

Get a glimpse of the in-depth analysis through our Report Brochure

The trend of practicing Yoga and Unani is gaining traction, and is more pronounced in Asia Pacific, which also happens to be the home to these therapies. Also, a high number of medical tourism activities observed in the region are likely to pass on the trend to developed countries, which could negatively impact the sales of drugs and devices related to asthma, thereby stunting the growth of the asthma treatment market space.

Long-term Asthma Control Medications to Outperform Quick-relief Medications

According to statistical data reported by the TMR study, the sales of long-term asthma control medications accounted for a value equal to ~US$ 14 Bn in 2018, and these drugs are projected to fast-penetrate the end-user space at a rate of ~3% during 2019-2027. A spurt in the growing popularity of these medications is due to the increase in the adoption of combination drugs for treating asthma, coupled with several studies establishing their effectiveness, when consumed for a prolonged duration.

Quick-relief medications have use only during asthma attacks, which makes them a less-significant drug in the asthma treatment market. To add to that, a high number of patent expirations and the advent of generic variants are further projected to impede their sales potential during the forecast period.

asthma treatment market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Asthma Treatment Market: Analysts’ View

Authors of the report opine that, the asthma treatment market will grow at a slow, yet steady pace, as long-term asthma control medications will bring continuous sales opportunities. Hospital pharmacies with the ability to maintain large inventories with essential drugs are likely to remain crucial; however, an increasing number of retail pharmacies, coupled with their easy accessibility, will drive significant revenue to the asthma treatment market. As the healthcare industry braces itself to embrace digitalization, online pharmacies will overcome the limitations of physical exposure in overseas territories. 

Asthma Treatment Market: Key Insights

  • Long-term asthma control medications and quick-relief (rescue) medications are the two types of drugs used to treat asthma.
  • Rescue inhalers and controller inhalers are used to treat the symptoms of asthma. However, to manage severe asthma cases, longer-acting inhalers are required, which can keep the airways open (formoterol, salmeterol, tiotropium) as well as be used as inhalant steroids.
  • Major types of long-term asthma control medications include combination inhalers, inhaled corticosteroids, long-acting beta agonists, leukotriene modifiers, theophylline, and others (reslizumab, benralizumab, etc.).
  • The combination inhalers sub-segment dominated the long-term asthma control medications segment in the asthma treatment market in 2018. The growth of this sub-segment can be attributed to the increase in the demand for combination inhalers, and promising drugs in the pipeline of the market.
  • The global asthma treatment market covers all drug types for different routes of administration to treat asthma in patients. Several drug companies are focusing on the development of promising drug molecules to improve treatment measures, which are beneficial for patients, by collaborating with research institutes and others companies. These factors are projected to drive the market during the forecast period. 

Asthma Treatment Market: Drivers

  • Asthma prevalence has been increasing despite advancements in treatment in the past two decades. Due to this, the global asthma treatment market is also expanding. Asthma prevalence ranges from 3% to 5% in developing countries, to less than 20% in developed countries, affecting people of all ages.
  • Focus on spreading awareness about asthma treatment, including common treatment options such as pressurized meter dose inhalers and dry powder inhalers, is fueling the global market.
  • Increase in the success rate of asthma treatment using combination therapy, such as long-acting muscarinic antagonist-inhaled corticosteroid (LAMA-ICS), long-acting β2-agonist-inhaled corticosteroid (LABA-ICS), and other combination drugs, and recent regulatory approvals have propelled the adoption of combination therapy in the global asthma treatment market.
  • Rising focus on smart or digital inhalers for the administration of asthma drugs is driving the global market.
  • The asthma treatment market is anticipated to be driven by increase in product approvals by the FDA and other regulatory bodies, rise in the prevalence of asthma, and strategic approaches such as collaborations & partnerships by market players. Rise in the opportunities for market players to expand their geographical presence in emerging countries will fuel the growth of the global asthma treatment market. 

Asthma Treatment Market: Key Segments

  • The global asthma treatment market has been segmented based on treatment type, route of administration, and distribution channel.
  • Under treatment type, the global market is dominated by the long-term asthma control medications segment, which will continue over the forecast period.
  • Under distribution channel, the global market is dominated by the retail pharmacies segment, which is expected to continue through the forecast period. 

Asthma Treatment Market: Key Regions

  • In terms of region, the global asthma treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.
  • North America holds a major share of the global market, while Asia Pacific is projected to expand at the highest CAGR over the forecast period. 

Asthma Treatment Market: Major Players 

  • The global asthma treatment report concludes with the company profiles section that includes key information about the major players in the market.
  • Leading players analyzed in the report are
    • Mylan N.V.
    • AstraZeneca plc.
    • Boehringer Ingelheim International GmbH
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc.
    • Merck & Co., Inc.
    • Novartis AG
    • Sanofi
    • Sunovion Pharmaceuticals, Inc.
    • Teva Pharmaceutical Industries
  • Each of these players have been profiled in the global market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Asthma Treatment Market – Scope of the Report 

TMR’s report on the global asthma treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global market for the period of 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global market from 2019 to 2027. 

The report has been prepared after an extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global asthma treatment market. 

Secondary research includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approaches to study various attributes of the global asthma treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global asthma treatment market. These serve as valuable tools for existing market players as well as for entities interested in entering in the global market. 

The report delves into the competitive landscape of the global asthma treatment market. Key players operating in the global market have been identified, and each one of them has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of the players in the market that have been profiled in this report. 

Key Questions Answered in the Asthma Treatment Market Report 

  • What is the sales/revenue projected to be generated by the market across all regions during the forecast period?
  • What are the opportunities in the global market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which treatment type is expected to generate the highest revenue globally in 2027? Which segment is projected expand at the highest CAGR during the forecast period?
  • What is the market positions of different companies operating in the global market? 

Global Asthma Treatment Market – Research Objectives and Research Approach 

The comprehensive report on the global asthma treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study, key vendors and distributors operating in the market, and regulatory scenario for the approval of products. 

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Global Asthma Treatment Market – Segmentation

TMR’s study on the global asthma treatment market includes information divided into four segments: treatment type, route of administration, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global asthma treatment market have been discussed in detail.

Treatment Type

Long-term Asthma Control Medications

Quick-relief (Rescue) Medications

Route of Administration

Inhaled

Oral

Intravenous

Subcutaneous

Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Asthma Treatment Market

4. Market Overview

    4.1.  Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities 

    4.4. Global Asthma Treatment Market Analysis and Forecast, 2017–2027

5. Market Outlook

    5.1. Pipeline Analysis

    5.2. Reimbursement Scenario 

    5.3. Disease Prevalence with Key Countries

6. Global Asthma Treatment Market Analysis and Forecasts, by Treatment Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

        6.3.1. Long-term Asthma Control Medications

            6.3.1.1. Inhaled Corticosteroids

            6.3.1.2. Leukotriene Modifiers

            6.3.1.3. Long-acting Beta Agonists

            6.3.1.4. Combination Inhalers

            6.3.1.5. Theophylline

            6.3.1.6. Others (reslizumab, benralizumab, etc.) 

        6.3.2. Quick-relief (rescue) Medications

            6.3.2.1. Short-acting Beta Agonists

            6.3.2.2. Ipratropium (Atrovent)

            6.3.2.3. Oral and Intravenous Corticosteroids

    6.4. Global Asthma Treatment Market Attractiveness, by Treatment Type

7. Global Asthma Treatment Market Analysis and Forecasts, by Route of Administration

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Asthma Treatment Market Value (US$) Forecast, by Route of Administration, 2017–2027

        7.3.1. Oral

        7.3.2. Inhaled

        7.3.3. Intravenous

        7.3.4. Subcutaneous

    7.4. Global Asthma Treatment Market Attractiveness, by Route of Administration

8. Global Asthma Treatment Market Analysis and Forecasts, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Global Asthma Treatment Market Attractiveness, by Distribution Channel

9. Global Asthma Treatment Market Analysis and Forecasts, by Region

    9.1. Key Findings

    9.2. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Asthma Treatment Market Attractiveness, by Region

10. North America Asthma Treatment Market Analysis and Forecast

    10.1. Introduction

    10.2. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

        10.2.1. Long-term Asthma Control Medications

            10.2.1.1. Inhaled Corticosteroids

            10.2.1.2. Leukotriene Modifiers

            10.2.1.3. Long-acting Beta Agonists

            10.2.1.4. Combination Inhalers

            10.2.1.5. Theophylline

            10.2.1.6. Others (reslizumab, benralizumab, etc.)

        10.2.2. Quick-relief (rescue) Medications

            10.2.2.1. Short-acting Beta Agonists

            10.2.2.2. Ipratropium (Atrovent)

            10.2.2.3. Oral and Intravenous Corticosteroids

    10.3. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

        10.3.1. Oral

        10.3.2. Inhaled

        10.3.3. Intravenous

        10.3.4. Subcutaneous

    10.4. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Online Pharmacies

    10.5. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Asthma Treatment Market Attractiveness Analysis

        10.6.1. By Treatment Type

        10.6.2. By Route of Administration

        10.6.3. By Distribution Channel

        10.6.4. By Country/Sub-region 

11. Europe Asthma Treatment Market Analysis and Forecast

    11.1. Introduction

    11.2. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

        11.2.1. Long-term Asthma Control Medications

            11.2.1.1. Inhaled Corticosteroids

            11.2.1.2. Leukotriene Modifiers

            11.2.1.3. Long-acting Beta Agonists

            11.2.1.4. Combination Inhalers

            11.2.1.5. Theophylline

            11.2.1.6. Others (reslizumab, benralizumab etc.)

        11.2.2. Quick-relief (rescue) Medications

            11.2.2.1. Short-acting Beta Agonists

            11.2.2.2. Ipratropium (Atrovent)

            11.2.2.3. Oral and Intravenous Corticosteroids

    11.3. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

        11.3.1. Oral

        11.3.2. Inhaled

        11.3.3. Intravenous

        11.3.4. Subcutaneous

    11.4. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Online Pharmacies

    11.5. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Asthma Treatment Market Attractiveness Analysis

        11.6.1. By Treatment Type

        11.6.2. By Route of Administration

        11.6.3. By Distribution Channel

        11.6.4. By Country/Sub-region 

12. Asia Pacific Asthma Treatment Market Analysis and Forecast

    12.1. Introduction

    12.2. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

        12.2.1. Long-term Asthma Control Medications

            12.2.1.1. Inhaled Corticosteroids

            12.2.1.2. Leukotriene Modifiers

            12.2.1.3. Long-acting Beta Agonists

            12.2.1.4. Combination Inhalers

            12.2.1.5. Theophylline

            12.2.1.6. Others (reslizumab, benralizumab etc.)

        12.2.2. Quick-relief (rescue) Medications

            12.2.2.1. Short-acting Beta Agonists

            12.2.2.2. Ipratropium (Atrovent)

            12.2.2.3. Oral and Intravenous Corticosteroids

    12.3. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

        12.3.1. Oral

        12.3.2. Inhaled

        12.3.3. Intravenous

        12.3.4. Subcutaneous

    12.4. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Online Pharmacies

    12.5. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Asthma Treatment Market Attractiveness Analysis

        12.6.1. By Treatment Type

        12.6.2. By Route of Administration

        12.6.3. By Distribution Channel

        12.6.4. By Country/Sub-region 

13. Latin America Asthma Treatment Market Analysis and Forecast

    13.1. Introduction

    13.2. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

        13.2.1. Long-term Asthma Control Medications

            13.2.1.1. Inhaled Corticosteroids

            13.2.1.2. Leukotriene Modifiers

            13.2.1.3. Long-acting Beta Agonists

            13.2.1.4. Combination Inhalers

            13.2.1.5. Theophylline

            13.2.1.6. Others (reslizumab, benralizumab etc.)

        13.2.2. Quick-relief (rescue) Medications

            13.2.2.1. Short-acting Beta Agonists

            13.2.2.2. Ipratropium (Atrovent)

            13.2.2.3. Oral and Intravenous Corticosteroids

    13.3. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

        13.3.1. Oral

        13.3.2. Inhaled

        13.3.3. Intravenous

        13.3.4. Subcutaneous

    13.4. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Online Pharmacies

    13.5. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Asthma Treatment Market Attractiveness Analysis

        13.6.1. By Treatment Type

        13.6.2. By Route of Administration

        13.6.3. By Distribution Channel

        13.6.4. By Country/Sub-region 

14. Middle East & Africa Asthma Treatment Market Analysis and Forecast

    14.1. Introduction

    14.2. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

        14.2.1. Long-term Asthma Control Medications

            14.2.1.1. Inhaled Corticosteroids

            14.2.1.2. Leukotriene Modifiers

            14.2.1.3. Long-acting Beta Agonists

            14.2.1.4. Combination Inhalers

            14.2.1.5. Theophylline

            14.2.1.6. Others (reslizumab, benralizumab etc.)

        14.2.2. Quick-relief (rescue) Medications

            14.2.2.1. Short-acting Beta Agonists

            14.2.2.2. Ipratropium (Atrovent)

            14.2.2.3. Oral and Intravenous Corticosteroids

    14.3. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

        14.3.1. Oral

        14.3.2. Inhaled

        14.3.3. Intravenous

        14.3.4. Subcutaneous

    14.4. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        14.4.1. Hospital Pharmacies

        14.4.2. Retail Pharmacies

        14.4.3. Online Pharmacies

    14.5. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

        14.5.1. GCC 

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Asthma Treatment Market Attractiveness Analysis

        14.6.1. By Treatment Type

        14.6.2. By Route of Administration

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region 

15. Competition Landscape

    15.1. Market Share Analysis, by Company (2018)

    15.2. Company Profiles

        15.2.1. AstraZeneca 

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Company Financials

            15.2.1.3. Growth Strategies

            15.2.1.4. SWOT Analysis

        15.2.2. Boehringer Ingelheim International GmbH 

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Company Financials

            15.2.2.3. Growth Strategies

            15.2.2.4. SWOT Analysis

        15.2.3. GlaxoSmithKline plc 

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Company Financials

            15.2.3.3. Growth Strategies

            15.2.3.4. SWOT Analysis

        15.2.4. Novartis AG 

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Company Financials

            15.2.4.3. Growth Strategies

            15.2.4.4. SWOT Analysis

        15.2.5. Teva Pharmaceutical Industries Ltd 

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Company Financials

            15.2.5.3. Growth Strategies

            15.2.5.4. SWOT Analysis

        15.2.6. Sumitomo Dainippon Pharma Co., Ltd 

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Company Financials

            15.2.6.3. Growth Strategies

            15.2.6.4. SWOT Analysis

        15.2.7. Merck & Co., Inc. 

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Company Financials

            15.2.7.3. Growth Strategies

            15.2.7.4. SWOT Analysis

        15.2.8. F. Hoffmann-La Roche Ltd. 

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Company Financials

            15.2.8.3. Growth Strategies

            15.2.8.4. SWOT Analysis

        15.2.9. Sanofi 

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Company Financials

            15.2.9.3. Growth Strategies

            15.2.9.4. SWOT Analysis

        15.2.10. Mylan N.V.

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Company Financials

            15.2.10.3. Growth Strategies

            15.2.10.4. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis 

Table 02: Pipeline Analysis 

Table 03: Pipeline Analysis 

Table 04: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 05: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 06: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 07: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 08: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 09: Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 10: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 11: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 12: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 13: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 14: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 17: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 18: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 19: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 20: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 21: Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 23: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 24: Asia Pacific  Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 25: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 26: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 27: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 28: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 29: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 30: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 31: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 32: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 33: Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

Table 35: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Long-term Asthma Control Medications, 2017–2027

Table 36: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Quick-relief (rescue) Medications, 2017–2027

Table 37: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 38: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 39: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global Asthma Treatment Market Value (US$ Mn) and Distribution Channel, by Region, 2018 and 2027

Figure 02: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 03: Global Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 04: Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Long-term Asthma Control Medications, 2017–2027

Figure 05: Global Asthma Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Quick-relief (rescue) Medications, 2017–2027

Figure 06: Global Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 07: Global Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 08: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhaled, 2017–2027

Figure 09: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017–2027

Figure 10: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2017–2027

Figure 11: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2017–2027

Figure 12: Global Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 13: Global Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 14: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017–2027

Figure 15: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017–2027

Figure 16: Global Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017–2027

Figure 17: Global Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 18: Global Asthma Treatment Market Value Share Analysis, by Region, 2018 and 2027

Figure 19: Global Asthma Treatment Market Attractiveness Analysis, by Region, 2019–2027

Figure 20: North America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 21: North America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 22: North America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 23: North America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 24: North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 25: North America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 26: North America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 27: North America Asthma Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America Asthma Treatment Market Attractiveness Analysis, by Country, 2019–2027

Figure 29: Europe Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 30: Europe Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 31: Europe Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 32: Europe Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 33: Europe Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 34: Europe Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 35: Europe Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 36: Europe Asthma Treatment Market Value Share Analysis, by Country/Sub-Region, 2018 and 2027

Figure 37: Europe Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 38: Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 39: Asia Pacific Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 40: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2017–2027

Figure 41: Asia Pacific Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 42: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 43: Asia Pacific Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 44: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 - 2027

Figure 45: Asia Pacific Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Asia Pacific Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 47: Latin America Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 48: Latin America Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 49: Latin America Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 50: Latin America Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 51: North America Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 52: Latin America Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 53: Latin America Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027

Figure 54: Latin America Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Latin America Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 56: Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 57: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 58: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Treatment Type, 2019–2027

Figure 59: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027

Figure 60: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Route of Administration, 2019–2027

Figure 61: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 62: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Distribution Channel, 2019?2027

Figure 63: Middle East & Africa Asthma Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Middle East & Africa Asthma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 65: Global Asthma Treatment Market Share, by Company, 2018

Figure 66: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 67: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 68: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018

Figure 69: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 70: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018

Figure 71: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 72: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018

Figure 73: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 74: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018

Figure 75: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 76: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018

Figure 77: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 78: Novartis AG Breakdown of Net Sales (%), by Country, 2018

Figure 79: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 80: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018

Figure 81: Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 82: Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 83: Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Segment, 2018

Figure 84: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 85: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017

Figure 86: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 87: Breakdown of Sumitomo Dainippon Pharma Co., Ltd Net Sales (%), by Product Segment, 2017

Figure 88: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 90: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 91: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 92: F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 93: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Region, 2018

Figure 94: F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 95: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 96: Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 97: Sanofi Breakdown of Net Sales (%), by Region, 2018

Figure 98: Sanofi Revenue Breakdown of Net Sales (%), by Business segment, 2018

Figure 99: Sanofi R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 100: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 101: Mylan N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015-2018

Figure 102: Mylan N.V. Breakdown of Net Sales (%), by Region, 2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Asthma Treatment Market